80 FR 34693 - Manufacturer of Controlled Substances Registration: Siemens Healthcare Diagnostics, Inc.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 80, Issue 116 (June 17, 2015)
Drug Enforcement Administration
Federal Register Volume 80, Issue 116 (June 17, 2015)
| Page Range | 34693-34693 | |
| FR Document | 2015-14912 |
[Federal Register Volume 80, Number 116 (Wednesday, June 17, 2015)] [Notices] [Page 34693] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2015-14912] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Manufacturer of Controlled Substances Registration: Siemens Healthcare Diagnostics, Inc. ACTION: Notice of registration. ----------------------------------------------------------------------- SUMMARY: Siemens Healthcare Diagnostics, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Siemens Healthcare Diagnostics, Inc. registration as a manufacturer of those controlled substances. SUPPLEMENTARY INFORMATION: By notice dated January 9, 2015, and published in the Federal Register on January 26, 2015, 80 FR 3982, Siemens Healthcare Diagnostics, Inc., Attn: RA, 100 GBC Drive, Mailstop 514, Newark, Delaware 19702 applied to be registered as a manufacturer of certain basic classes of controlled substances. No comments or objections were submitted to this notice. The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Siemens Healthcare Diagnostics, Inc. to manufacture the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company's maintenance of effective controls against diversion by inspecting and testing the company's physical security systems, verifying the company's compliance with state and local laws, and reviewing the company's background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above-named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed: ------------------------------------------------------------------------ Controlled substance Schedule ------------------------------------------------------------------------ Tetrahydrocannabinols (7370)............... I Ecgonine (9180)............................ II Morphine (9300)............................ II Thebaine (9333)............................ II ------------------------------------------------------------------------ The company plans to produce the listed controlled substances in bulk to be used in the manufacture of reagents and drug calibrator controls which are DEA exempt products. In reference to drug code 7370 the company plans to bulk manufacture a synthetic tetrahydrocannabinol. No other activity for this drug code is authorized for this registration. Dated: June 11, 2015. Joseph T. Rannazzisi, Deputy Assistant Administrator. [FR Doc. 2015-14912 Filed 6-16-15; 8:45 am] BILLING CODE 4410-09-P
![Federal Register / Vol. 80, No. 116 / Wednesday, June 17, 2015 / Notices 34693
management strategies for Fire Island continuation or recurrence of material the Federal Register on January 26,
National Seashore for the next 15 to 20 injury to an industry in the United 2015, 80 FR 3982, Siemens Healthcare
years to support the protection of States within a reasonably foreseeable Diagnostics, Inc., Attn: RA, 100 GBC
important natural resources and time. Drive, Mailstop 514, Newark, Delaware
processes; significant recreation 19702 applied to be registered as a
Background
resources; cultural resources of national, manufacturer of certain basic classes of
state, and local significance; and The Commission, pursuant to section controlled substances. No comments or
residential communities. 751(c) of the Tariff Act of 1930 (19 objections were submitted to this notice.
The park is composed of two distinct U.S.C. 1675(c)), instituted these reviews The DEA has considered the factors in
units—the barrier island that runs on April 1, 2014 (79 FR 18311) and 21 U.S.C. 823(a) and determined that
parallel to the south shore of Long determined on July 7, 2014 that it would the registration of Siemens Healthcare
Island and the 613-acre William Floyd conduct full reviews (79 FR 42049, July Diagnostics, Inc. to manufacture the
Estate situated on the south shore of 18, 2014). Notice of the scheduling of basic classes of controlled substances is
Long Island near the east end of Fire the Commission’s reviews and of a consistent with the public interest and
Island. To address the specific needs of public hearing to be held in connection with United States obligations under
these two distinct units, the Draft GMP/ therewith was given by posting copies international treaties, conventions, or
EIS includes two sets of alternatives. of the notice in the Office of the protocols in effect on May 1, 1971. The
One addresses park-wide alternatives Secretary, U.S. International Trade DEA investigated the company’s
for Fire Island National Seashore with a Commission, Washington, DC, and by maintenance of effective controls
primary emphasis on the barrier island publishing the notice in the Federal against diversion by inspecting and
and includes a no-action alternative and Register on November 14, 2014 (79 FR testing the company’s physical security
two action alternatives. The other set of 68299). The hearing was held in systems, verifying the company’s
alternatives focuses specifically on the Washington, DC, on March 26, 2015, compliance with state and local laws,
William Floyd Estate and includes a no- and all persons who requested the and reviewing the company’s
action and a single action alternative. opportunity were permitted to appear in background and history.
The Draft GMP/EIS also incorporates person or by counsel. Therefore, pursuant to 21 U.S.C.
plans for the Otis Pike High Dunes Fire The Commission made these 823(a), and in accordance with 21 CFR
Island Wilderness and includes a draft determinations pursuant to section 1301.33, the above-named company is
Wilderness Stewardship Plan for public 751(c) of the Tariff Act of 1930 (19 granted registration as a bulk
review concurrent with the Draft GMP/ U.S.C. 1675(c)). It completed and filed manufacturer of the basic classes of
EIS. its determinations in these reviews on controlled substances listed:
FOR FURTHER INFORMATION CONTACT: June 11, 2015. The views of the
Ellen Carlson, NPS/Northeast Region, 15 Commission are contained in USITC Controlled substance Schedule
State Street, Boston, MA 02019. Phone: Publication 4538 (June 2015), entitled
Citric Acid and Certain Citrate Salts Tetrahydrocannabinols (7370) ..... I
(617) 223–5048. Email: Fire_Island_
from Canada and China: Investigation Ecgonine (9180) ........................... II
GMP@nps.gov. Morphine (9300) ........................... II
Nos. 701–TA–456 and 731–TA–1151–
Dated: June 1, 2015. 1152 (Review). Thebaine (9333) ........................... II
Michael A. Caldwell,
By order of the Commission. The company plans to produce the
Regional Director, Northeast Region, National
Park Service. Issued: June 12, 2015. listed controlled substances in bulk to
[FR Doc. 2015–14927 Filed 6–16–15; 8:45 am] Lisa R. Barton, be used in the manufacture of reagents
BILLING CODE 4310–WV–P
Secretary to the Commission. and drug calibrator controls which are
[FR Doc. 2015–14863 Filed 6–16–15; 8:45 am] DEA exempt products.
BILLING CODE 7020–02–P In reference to drug code 7370 the
INTERNATIONAL TRADE company plans to bulk manufacture a
COMMISSION synthetic tetrahydrocannabinol. No
DEPARTMENT OF JUSTICE other activity for this drug code is
[Investigation Nos. 701–TA–456 and 731– authorized for this registration.
TA–1151–1152 (Review)] Drug Enforcement Administration Dated: June 11, 2015.
Citric Acid and Certain Citrate Salts [Docket No. DEA–392] Joseph T. Rannazzisi,
From Canada and China Deputy Assistant Administrator.
Manufacturer of Controlled [FR Doc. 2015–14912 Filed 6–16–15; 8:45 am]
Determination Substances Registration: Siemens BILLING CODE 4410–09–P
On the basis of the record 1 developed Healthcare Diagnostics, Inc.
in the subject five-year reviews, the
United States International Trade ACTION: Notice of registration.
DEPARTMENT OF JUSTICE
Commission (‘‘Commission’’) SUMMARY: Siemens Healthcare
determines, pursuant to the Tariff Act of Diagnostics, Inc. applied to be registered Drug Enforcement Administration
1930, that revocation of the as a manufacturer of certain basic [Docket No. DEA–411F]
asabaliauskas on DSK5VPTVN1PROD with NOTICES
countervailing duty order on citric acid classes of controlled substances. The
and certain citrate salts from China and Drug Enforcement Administration Adjusted Aggregate Production
the antidumping duty orders on citric (DEA) grants Siemens Healthcare Quotas for Difenoxin, Diphenoxylate
acid and certain citrate salts from China Diagnostics, Inc. registration as a (for Conversion), and Marijuana
and Canada would be likely to lead to manufacturer of those controlled
substances. AGENCY: Drug Enforcement
1 Therecord is defined in sec. 207.2(f) of the Administration, Department of Justice.
Commission’s Rules of Practice and Procedure (19 SUPPLEMENTARY INFORMATION: By notice
ACTION: Final order.
CFR 207.2(f)). dated January 9, 2015, and published in
VerDate Sep<11>2014 18:47 Jun 16, 2015 Jkt 235001 PO 00000 Frm 00088 Fmt 4703 Sfmt 4703 E:\FR\FM\17JNN1.SGM 17JNN1](https://thefederalregister.org/doc/80_FR_34809/page/1.svg)
Document Created: 2015-12-15 14:22:23
Document Modified: 2015-12-15 14:22:23
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of registration. | |
| FR Citation | 80 FR 34693 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR